Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network.
Ghilli M, Becherini C, Meattini I, Angiolini C, Bengala C, Marconi A, Galli L, Angiolucci G, Coltelli L, Borghesi S, Lastrucci L, Manca G, Bianchi S, Doria M, Casella D, Marotti L, Amunni G, Roncella M. Ghilli M, et al. Among authors: becherini c. Radiol Med. 2024 Apr 29. doi: 10.1007/s11547-024-01818-7. Online ahead of print. Radiol Med. 2024. PMID: 38683499
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques.
Salvestrini V, Valzano M, Meattini I, Becherini C, Visani L, Francolini G, Morelli I, Bertini N, Orzalesi L, Bernini M, Bianchi S, Simontacchi G, Livi L, Desideri I. Salvestrini V, et al. Among authors: becherini c. Radiol Med. 2024 Apr 11. doi: 10.1007/s11547-024-01812-z. Online ahead of print. Radiol Med. 2024. PMID: 38602657
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures.
Bernini M, Gigliucci G, Cassetti D, Tommasi C, Gaggelli I, Arlia L, Becherini C, Salvestrini V, Visani L, Nori Cucchiari J, De Benedetto D, Di Naro F, Bicchierai G, Bellini C, Bianchi S, Orzalesi L, Livi L, Meattini I. Bernini M, et al. Among authors: becherini c. Gland Surg. 2024 Mar 27;13(3):297-306. doi: 10.21037/gs-23-432. Epub 2024 Mar 22. Gland Surg. 2024. PMID: 38601291 Free PMC article.
Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature.
Becherini C, Salvestrini V, Desideri I, Vagnoni G, Bonaparte I, Bertini N, Mattioli C, Angelini L, Visani L, Scotti V, Livi L, Caini S, Bonomo P. Becherini C, et al. Radiol Med. 2024 Mar;129(3):457-466. doi: 10.1007/s11547-024-01757-3. Epub 2024 Feb 14. Radiol Med. 2024. PMID: 38351333 Free PMC article. Review.
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
Meattini I, Becherini C, Caini S, Coles CE, Cortes J, Curigliano G, de Azambuja E, Isacke CM, Harbeck N, Kaidar-Person O, Marangoni E, Offersen BV, Rugo HS, Salvestrini V, Visani L, Morandi A, Lambertini M, Poortmans P, Livi L; Consensus Panellist Group. Meattini I, et al. Among authors: becherini c. Lancet Oncol. 2024 Feb;25(2):e73-e83. doi: 10.1016/S1470-2045(23)00534-X. Lancet Oncol. 2024. PMID: 38301705 Review.
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO).
Kaidar-Person O, Meattini I, Boersma LJ, Becherini C, Cortes J, Curigliano G, de Azambuja E, Harbeck N, Rugo HS, Del Mastro L, Gennari A, Isacke CM, Vestmø Maraldo M, Marangoni E, Nader Marta G, Mjaaland I, Salvestrini V, Spanic T, Visani L, Morandi A, Lambertini M, Livi L, Coles CE, Poortmans P, Offersen BV. Kaidar-Person O, et al. Among authors: becherini c. Radiother Oncol. 2024 Jun;195:110060. doi: 10.1016/j.radonc.2023.110060. Epub 2023 Dec 19. Radiother Oncol. 2024. PMID: 38122852 Free article. Review.
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort.
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L. Francolini G, et al. Among authors: becherini c. Radiol Med. 2023 Dec;128(12):1580-1588. doi: 10.1007/s11547-023-01721-7. Epub 2023 Sep 20. Radiol Med. 2023. PMID: 37728816
81 results